As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
Vial is a contract research organisation that runs clinical trials on its own software stack for electronic data capture and site management. It argues that owning the technology cuts the cost and duration of a trial compared with legacy CROs. The company focuses on dermatology, ophthalmology and other specialty indications.
News
From Sharpie markings to reliable vial labeling in analytical development
Discover why analytical development teams are moving beyond Sharpie markings and manual labels to improve vial identification.
Read more
Report
How to improve vial labeling in compound management workflows
Improve vial labelling in compound management workflows to reduce errors and strengthen sample traceability.
Read more
Report
Vial Doses First Patient for Phase 1 Trial of Vial's IL-13 x TSLP, a Novel Bispecific Antibody
Vial's IL13 x TSLP is a half-life-extended bispecific antibody engineered for projected quarterly-to-biannual dosing Preclinical data demonstrates picomolar binding affinities for both IL-13 and TSLP, with near-complete inhibition of CCL17 secretion versu
Read more
Report
Vial is geared up to attend the 44th Annual J.P. Morgan Healthcare Conference in San Francisco
Vial is geared up to attend the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.
Read more
Report
Pro access
Upgrade to see all 27 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ
